News Classic

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday.

The Dow traded up 0.77% to 42,440.12 while the NASDAQ rose 0.46% to 18,603.67. The S&P 500 also rose, gaining, 0.43% to 5,832.99.

Check This Out: How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings

Leading and Lagging Sectors

Financials shares rose by 1.2% on Monday.

In trading on Monday, energy shares fell by 0.7%.

Top Headline

Koninklijke Philips NV PHG reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros. The Dutch conglomerate reported sales of 4.38 billion euros ($4.74 billion), down 2% year over year and missing the consensus of 4.54 billion euros.

Equities Trading UP
                       

• Healthcare Triangle, Inc. HCTI shares shot up 106% to $1.19  after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.
• Shares of Autonomix Medical, Inc. AMIX got a boost, surging 70% to $13.08  after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.
• Evoke Pharma, Inc. EVOK shares were also up, gaining 52% to $7.78 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.

Equities Trading DOWN

• Koninklijke Philips N.V. PHG shares dropped 16% to $26.52 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.
• Shares of Borr Drilling Limited BORR were down 7% to $4.38. The stock may be moving on continued weakness following Friday’s reported preliminary third-quarter financial results.
• CEMEX, S.A.B. de C.V. CX was down, falling 9% to $5.46 following weak quarterly results.

Commodities

In commodity news, oil traded down 6% to $67.49 while gold traded down 0.1% at $2,754.40.

Silver traded up 0.2% to $33.850 on Monday, while copper fell 0.1% to $4.3655.

Euro zone

European shares closed higher today. The eurozone’s STOXX 600 gained 0.41%, Germany’s DAX rose 0.35% and France’s CAC 40 rose 0.79%. Spain’s IBEX 35 Index rose 0.77%, while London’s FTSE 100 rose 0.45%.

Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.

Asia Pacific Markets

Asian markets closed higher on Monday, with Japan’s Nikkei 225 gaining 1.82%, Hong Kong’s Hang Seng Index gaining 0.05%, China’s Shanghai Composite Index gaining 0.68% and India’s BSE Sensex surging 0.76%.

Hong Kong’s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.

Economics

The Federal Reserve Bank of Dallas’ general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month.

Now Read This:

Harmony Biosciences HRMY is set to give its latest quarterly earnings report on Tuesday, 2024-10-29. Here’s what investors need to know before the announcement.

Analysts estimate that Harmony Biosciences will report an earnings per share (EPS) of $0.66.

Harmony Biosciences bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Earnings Track Record

The company’s EPS beat by $1.11 in the last quarter, leading to a 2.19% increase in the share price on the following day.

Here’s a look at Harmony Biosciences’s past performance and the resulting price change:

Performance of Harmony Biosciences Shares

Shares of Harmony Biosciences were trading at $34.5 as of October 25. Over the last 52-week period, shares are up 51.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Harmony Biosciences visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Modine Manufacturing MOD is preparing to release its quarterly earnings on Tuesday, 2024-10-29. Here’s a brief overview of what investors should keep in mind before the announcement.

Analysts expect Modine Manufacturing to report an earnings per share (EPS) of $0.92.

The market awaits Modine Manufacturing’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It’s important for new investors to understand that guidance can be a significant driver of stock prices.

Performance in Previous Earnings

Last quarter the company beat EPS by $0.18, which was followed by a 18.94% increase in the share price the next day.

Here’s a look at Modine Manufacturing’s past performance and the resulting price change:

Performance of Modine Manufacturing Shares

Shares of Modine Manufacturing were trading at $127.25 as of October 25. Over the last 52-week period, shares are up 229.08%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Insights Shared by Analysts on Modine Manufacturing

For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Modine Manufacturing.

The consensus rating for Modine Manufacturing is Buy, based on 6 analyst ratings. With an average one-year price target of $141.5, there’s a potential 11.2% upside.

Comparing Ratings with Competitors

The following analysis focuses on the analyst ratings and average 1-year price targets of Gentex, Autoliv and BorgWarner, three prominent industry players, providing insights into their relative performance expectations and market positioning.

• The consensus outlook from analysts is an Neutral trajectory for Gentex, with an average 1-year price target of $34.25, indicating a potential 73.08% downside.
• As per analysts’ assessments, Autoliv is favoring an Neutral trajectory, with an average 1-year price target of $111.83, suggesting a potential 12.12% downside.
• For BorgWarner, analysts project an Outperform trajectory, with an average 1-year price target of $43.0, indicating a potential 66.21% downside.

Key Findings: Peer Analysis Summary

The peer analysis summary provides a snapshot of key metrics for Gentex, Autoliv and BorgWarner, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

Key Takeaway:

Modine Manufacturing ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.

All You Need to Know About Modine Manufacturing

Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers.

Financial Milestones: Modine Manufacturing’s Journey

Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.

Revenue Growth: Over the 3 months period, Modine Manufacturing showcased positive performance, achieving a revenue growth rate of 6.28% as of 30 June, 2024. This reflects a substantial increase in the company’s top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.

Net Margin: Modine Manufacturing’s net margin is impressive, surpassing industry averages. With a net margin of 7.15%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Modine Manufacturing’s ROE excels beyond industry benchmarks, reaching 6.16%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): The company’s ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.54%, the company showcases effective utilization of assets.

Debt Management: Modine Manufacturing’s debt-to-equity ratio is below the industry average at 0.55, reflecting a lower dependency on debt financing and a more conservative financial approach.

To track all earnings releases for Modine Manufacturing visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

ExlService Holdings EXLS will release its quarterly earnings report on Tuesday, 2024-10-29. Here’s a brief overview for investors ahead of the announcement.

Analysts anticipate ExlService Holdings to report an earnings per share (EPS) of $0.41.

ExlService Holdings bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

The company’s EPS beat by $0.01 in the last quarter, leading to a 4.13% increase in the share price on the following day.

Here’s a look at ExlService Holdings’s past performance and the resulting price change:

Market Performance of ExlService Holdings’s Stock

Shares of ExlService Holdings were trading at $38.6 as of October 25. Over the last 52-week period, shares are up 48.79%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analysts’ Perspectives on ExlService Holdings

Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on ExlService Holdings.

ExlService Holdings has received a total of 5 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $41.8, the consensus suggests a potential 8.29% upside.

Comparing Ratings Among Industry Peers

The below comparison of the analyst ratings and average 1-year price targets of Genpact, Verra Mobility and Concentrix, three prominent players in the industry, gives insights for their relative performance expectations and market positioning.

• Genpact is maintaining an Neutral status according to analysts, with an average 1-year price target of $41.17, indicating a potential 6.66% upside.
• For Verra Mobility, analysts project an Neutral trajectory, with an average 1-year price target of $29.0, indicating a potential 24.87% downside.
• The prevailing sentiment among analysts is an Outperform trajectory for Concentrix, with an average 1-year price target of $80.43, implying a potential 108.37% upside.

Comprehensive Peer Analysis Summary

The peer analysis summary provides a snapshot of key metrics for Genpact, Verra Mobility and Concentrix, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

Key Takeaway:

ExlService Holdings ranks first in revenue growth among its peers. It ranks lowest in gross profit and return on equity.

About ExlService Holdings

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage company’s deep expertise in analytics, AI, ML and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging, Analytics. The vast majority of the company’s revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

ExlService Holdings: Delving into Financials

Market Capitalization: Surpassing industry standards, the company’s market capitalization asserts its dominance in terms of size, suggesting a robust market position.

Revenue Growth: ExlService Holdings’s revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 10.71%. This indicates a substantial increase in the company’s top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: ExlService Holdings’s net margin excels beyond industry benchmarks, reaching 10.22%. This signifies efficient cost management and strong financial health.

Return on Equity (ROE): ExlService Holdings’s ROE stands out, surpassing industry averages. With an impressive ROE of 5.53%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): ExlService Holdings’s ROA surpasses industry standards, highlighting the company’s exceptional financial performance. With an impressive 3.11% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.49.

To track all earnings releases for ExlService Holdings visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.